Date: Nov 19, 2013 Author: press release Source: Company Data (
click here to go to the source)
Palo Alto, Calif., November 19, 2013 —Health Fidelity, a leading healthcare big data company, is making its cloud-based REVEAL product available for research use. REVEAL, Health Fidelity's natural language processing (NLP) platform, converts unstructured clinical notes into rich, fully structured and coded content in real-time. The product will support experienced researchers in leveraging the full clinical record rather than claims or discrete data alone. The cloud-based service will be offered through a one year research license for a $1,000 set up fee. A qualified principal investigator and a defined research protocol are required.
"The nation expects to see positive results from its enormous investment in healthcare information technology. The information is available and electronic. Healthcare organizations, industry and researchers must now come together to derive value from the full clinical record," said Dan Riskin, M.D., CEO and co-founder of Health Fidelity. "This research program is a small step toward delivering on a vision to leverage data to improve healthcare."
In recent years, the accuracy, usability, and breadth of commercial NLP technology has far surpassed open source systems based on heavy investment in research and development. As researchers aim to use the full clinical record to improve care, they will need advanced systems. REVEAL incorporates advanced clinical modeling defined and implemented under NSF and NIH funding and broad mapping to industry standard terminologies including ICD-9, ICD-10, SNOMED, RxNorm and LOINC. REVEAL also incorporates Columbia University's renowned MedLEE technology through exclusive license.
"REVEAL's advanced NLP capabilities generate a high-quality substrate for complex data mining projects to discover off-label drug use as well as drug related adverse events," said Dr. Nigam Shah, Assistant Professor at the Stanford Center for Biomedical Informatics Research. "We use REVEAL to create detailed feature maps of patients to ensure such adverse events do not occur."
George Hripsak, Chair of Department of Biomedical Informatics and Professor of Biomedical Informatics at Columbia University, states: "Columbia is delighted to see the power of MedLEE enhanced and combined with robust clinical modeling and a full terminology set. Working with the secure cloud service offers rapid implementation, scalability and a constantly improving product. It can be a great boon for the research community."
To apply for this research program, or for more information, visit healthfidelity.com/research.
About Health Fidelity
Health Fidelity, Inc., based in Palo Alto, Calif., is a healthcare big data company providing industry leading cloud-based healthcare natural language processing (NLP) and unstructured data management solutions. Leveraging the longest standing clinical NLP technology with the most peer-reviewed literature and scientific citations, the company's REVEAL product is the world's most accurate, reliable and studied NLP technology in healthcare. It enables application developers and healthcare organizations to utilize vast amounts of unstructured clinical data to improve quality and efficiency of the care delivery process. Health Fidelity draws on its deep domain knowledge and understanding of medical language to unlock actionable information from this unstructured data.
Health Fidelity and REVEAL are trademarks of Health Fidelity, Inc. in the United States and/or other countries.
###
Media Contact:
Kate Ottavio
KNB Communications
203-504-8230
kottavio@knbpr.com
